Since 2022, many type 2 diabetes and weight-loss injectables (GLP-1's including, but not limited to Wegovy, Mounjaro, Ozempic, Saxenda, and Zepbound) have been on a national shortage. We have received a surge of phone calls in the past months from concerned patients and providers seeking to find a GLP-1 medication they cannot abruptly stop, or from patients looking to start new therapies. As an independent pharmacy who strives to help our community navigate through healthcare challenges, we wanted to educate on some alternatives that support our patients’ goals.
Lititz Apothecary has completed due diligence in compounding GLP-1 medication from FDA approved facilities. Injectable Semaglutide and Terzepatide are now available.
Cost:
Overall Process:
Once you complete this form, an onboarding specialist will reach out and go over the details.
How are we able to get these products?
When a medication is on the FDA backorder list compounding pharmacies and manufacturing pharmacies are able to manufacture the medication to meet demand.
My product was colored red before from other compounding pharmacies?
Some compounding pharmacies mix B-12 or other vitamins in their product and end up changing the overall color. Our product is untouched and sent directly from the manufacturer in a non-salt format.
Will I be provided education on how to draw up a syringe and inject themselves?
We understand this starts with patient education. We strongly encourage an onboarding consultation with each new patient, in which we go through expected side effects, storage requirements, how to draw up a syringe and injection techniques. We have the patient review, demonstrate, and then inject themselves during the onboarding process.
What does the patient journey look like once we receive the prescription?
Once we receive a compounded Rx: